These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 24512060)

  • 21. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
    Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
    Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer.
    Zeng X; Tao W; Mei L; Huang L; Tan C; Feng SS
    Biomaterials; 2013 Aug; 34(25):6058-67. PubMed ID: 23694904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
    Chen J; Li S; Shen Q
    Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
    Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
    Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration.
    Yu T; Xu B; He L; Xia S; Chen Y; Zeng J; Liu Y; Li S; Tan X; Ren K; Yao S; Song X
    Int J Nanomedicine; 2016; 11():743-59. PubMed ID: 26955272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway.
    Wang Y; Li J; Chen JJ; Gao X; Huang Z; Shen Q
    Mol Pharm; 2017 Apr; 14(4):1120-1132. PubMed ID: 28291364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
    Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y
    Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
    Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
    Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
    Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.